A Cambridge biotech is rebounding from an FDA rejection by signing a deal with drug…
eabramovichJuly 17, 2020
Glympse Bio secured $46.7 million in a Series B fundraising round that will be used to support continued…
eabramovichJuly 16, 2020
Mariella Filbin, MD, PhD, a neuro-oncologist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, is driven…
eabramovichJuly 15, 2020
3M and researchers from the Massachusetts Institute of Technology announced Tuesday a partnership to develop a…
eabramovichJuly 15, 2020
Now, in the largest study of its kind to date, researchers from BUSM, UC San…
eabramovichJuly 15, 2020
The Wyss Institute’s Biostasis project, which began just eighteen months ago as part of the Defense…
eabramovichJuly 14, 2020
Massachusetts General Hospital are the first to safely treat two research participants with a synthetic…
eabramovichJuly 14, 2020
Kymera Therapeutics, based in Cambridge, Massachusetts, entered a strategic collaboration deal with Paris-based Sanofi. They will focus on…
eabramovichJuly 13, 2020
The Imaging Platform at the Broad Institute of MIT and Harvard, together with industry and non-profit partners,…
eabramovichJuly 13, 2020
